- Home
- BRNS vs MGLD Comparison
BRNS vs MGLD Comparison
Compare BRNS & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRNS
- MGLD
- Stock Information
- Founded
- BRNS 2016
- MGLD 1996
- Country
- BRNS United Kingdom
- MGLD United States
- Employees
- BRNS N/A
- MGLD N/A
- Industry
- BRNS Biotechnology: Pharmaceutical Preparations
- MGLD Finance/Investors Services
- Sector
- BRNS Health Care
- MGLD Finance
- Exchange
- BRNS Nasdaq
- MGLD Nasdaq
- Market Cap
- BRNS 55.9M
- MGLD 44.8M
- IPO Year
- BRNS 2021
- MGLD N/A
- Fundamental
- Price
- BRNS $1.32
- MGLD $1.04
- Analyst Decision
- BRNS Strong Buy
- MGLD
- Analyst Count
- BRNS 1
- MGLD 0
- Target Price
- BRNS $3.00
- MGLD N/A
- AVG Volume (30 Days)
- BRNS 253.1K
- MGLD 5.3K
- Earning Date
- BRNS 11-06-2025
- MGLD 11-07-2025
- Dividend Yield
- BRNS N/A
- MGLD N/A
- EPS Growth
- BRNS N/A
- MGLD N/A
- EPS
- BRNS N/A
- MGLD N/A
- Revenue
- BRNS $14,969,000.00
- MGLD $30,154,000.00
- Revenue This Year
- BRNS N/A
- MGLD N/A
- Revenue Next Year
- BRNS N/A
- MGLD N/A
- P/E Ratio
- BRNS N/A
- MGLD N/A
- Revenue Growth
- BRNS 1766.46
- MGLD N/A
- 52 Week Low
- BRNS $0.64
- MGLD $0.64
- 52 Week High
- BRNS $2.92
- MGLD $2.10
- Technical
- Relative Strength Index (RSI)
- BRNS 50.56
- MGLD 51.06
- Support Level
- BRNS $1.23
- MGLD $1.02
- Resistance Level
- BRNS $1.50
- MGLD $1.09
- Average True Range (ATR)
- BRNS 0.13
- MGLD 0.05
- MACD
- BRNS -0.02
- MGLD -0.01
- Stochastic Oscillator
- BRNS 22.22
- MGLD 50.50
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.
About MGLD The Marygold Companies Inc.
The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.